GCL
CBMG

Glazer Capital LLC’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Glazer Capital LLC’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-232,103
Closed -$4.27M – 856
2020
Q4 		$4.27M Buy
232,103
+29,945
+15% +$546K 0.15% 158
2020
Q3 		$3.71M Buy
+202,158
New +$3.4M 0.18% 130

Glazer Capital LLC's CBMG Position: Q1 2021 in Review

Glazer Capital LLC sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 232,103 shares — an estimated $4.27M sold.

Glazer Capital LLC first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $4.27M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Glazer Capital LLC reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 232,103 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $4.27M.
  • Glazer Capital LLC first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Glazer Capital LLC's Cellular Biomedicine Group, Inc. position peaked at $4.27M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Glazer Capital LLC's 13F filing for Q1 2021, filed 14 May 2021.